✦ LIBER ✦

Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease

✍ Scribed by Keithi-Reddy, Sai Ram; Addabbo, Francesco; Patel, Tejas V; Mittal, Bharati V; Goligorsky, Michael S; Singh, Ajay K

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with erythropoiesis-stimulatin

✍ Hazzan, Azzour D; Shah, Hitesh H; Hong, Susana; Sakhiya, Vipulbhai; Wanchoo, Rim 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 181 KB

Intravenous Iron Versus Erythropoiesis-S

✍ Kalantar-Zadeh, Kamyar; Streja, Elani; Miller, Jessica E.; Nissenson, Allen R. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 330 KB

153: Dosing Intervals and Hemoglobin Con

✍ Saul Nurko; Rita Spirko; Amy Law; Vincent W. Dennis 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Safety issues related to erythropoiesis-

✍ Del Vecchio, Lucia; Locatelli, Francesco 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 240 KB

Management of anemia with erythropoietic

✍ Warady, Bradley A.; Silverstein, Douglas M. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 346 KB

PUK9 REAL-LIFE DOSING OF ERYTHROPOIESIS-

✍ Walsh, CM; Bilton, R; Robinson, JE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB